Cambridge Cognition acquires Winterlight Labs for £7m

OBIO NewsOntario Industry Updates
Written By Arsheen Kaur

Cambridge Cognition has acquired Canadian company Winterlight Labs Inc for £7m to target a $220m market for speech-based biomarkers. Based in Toronto, Winterlight focuses on machine-learning based voice assessments, using free-speech inputs or those that require deductive reasoning or interpretation.

Winterlight Labs is an OBIO® member, CAAP® company and BDSP™ recipient.

Arsheen Kaur
Previous

Kingston Health Sciences Centre ensures the beat goes on with virtual cardiac monitoring
Next

Notogen partners with Boehringer Ingelheim to develop a novel regenerative approach to treat degenerative disc disease